Teva Pharmaceuticals USA recalls Adenosine Injection, USP, 60mg/20mL (3 mg/mL), 20 mL single-dose vial, Rx only, Manufactured by: Teva Pharmaceuticals US
Recalled August 25, 2021 · FDA recall D-0740-2021 · Teva Pharmaceuticals USA
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
4,249 vials
Sold at
Product was distributed Nationwide, including Puerto Rico.
Description
Lack of Assurance of Sterility
Product
Adenosine Injection, USP, 60mg/20mL (3 mg/mL), 20 mL single-dose vial, Rx only, Manufactured by: Teva Pharmaceuticals USA Inc. Parsippany, NJ 07054, NDC 0703-8776-01
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →